Mesothelioma Clinical Trials Overview > Mesothelioma Clinical Trial List
An Open-Label, Phase II Trial of ZD1839 (IRESSA) in Patients With Malignant Mesothelioma
| Conditions: | Mesothelioma |
| Start Date: | September 1, 2003 |
| Phase: | Phase II |
| Status: | Completed |
| NCT ID: | NCT00787410 |
| Study Type: | Interventional |
| Intervention: | Drug: ZD1839 |
| Study Design: | Allocation: Non-Randomized|Endpoint Classification: Safety/Efficacy Study|Intervention Model: Single Group Assignment|Masking: Open Label|Primary Purpose: Treatment |
| Results: | No Results Available |
| Sponsors: | AstraZeneca|Dr.Christopher Lee |
| Ages: | Adult|Senior |
| Enrollment: | 23 |
| Funded By: | Industry|Other |
| First Received: | November 6, 2008 |
| End Date: | April 1, 2008 |
| Last Updated: | April 22, 2009 |
| Last Verified: | April 1, 2009 |
Mesothelioma
Lawsuit Evaluation
Lawsuit Evaluation
